Pipeline
Program/TargetProg/Tgt | Initial IndicationInd | DiscoveryDiscov | PreclinicalPreclin | ClinicalClin | Program StatusStatus | |
|---|---|---|---|---|---|---|
OKI-355 | ||||||
Vascular Anomalies | ||||||
OKI-355 PI3KαPAN mutant-selective inhibitor | Vascular Anomalies | IND Enabling Studies Ongoing | ||||
OKI-345 | ||||||
Breast Cancer | ||||||
OKI-345 PI3KαPAN mutant-selective inhibitor | Breast Cancer | IND Enabling Studies Ongoing | ||||